Association of HTR1F with Prognosis, Tumor Immune Microenvironment, and Drug Sensitivity in Cancer: A Multi-Omics Perspective

Yanjun Gao, Ziyue Zhang, Dafu Ye, Qingqing Li, Yingmei Wen, Shaowen Ma, Bo Zheng, Lei Chen, Yi Yao

Open source

DOI
10.3390/biomedicines13092238
Published
2025-09-11
Container
Biomedicines
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines13092238,
  title = {Association of HTR1F with Prognosis, Tumor Immune Microenvironment, and Drug Sensitivity in Cancer: A Multi-Omics Perspective},
  author = {Yanjun Gao and Ziyue Zhang and Dafu Ye and Qingqing Li and Yingmei Wen and Shaowen Ma and Bo Zheng and Lei Chen and Yi Yao},
  year = {2025},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines13092238},
  url = {https://doi.org/10.3390/biomedicines13092238}
}

RIS

TY  - JOUR
TI  - Association of HTR1F with Prognosis, Tumor Immune Microenvironment, and Drug Sensitivity in Cancer: A Multi-Omics Perspective
AU  - Yanjun Gao
AU  - Ziyue Zhang
AU  - Dafu Ye
AU  - Qingqing Li
AU  - Yingmei Wen
AU  - Shaowen Ma
AU  - Bo Zheng
AU  - Lei Chen
AU  - Yi Yao
PY  - 2025
JO  - Biomedicines
DO  - 10.3390/biomedicines13092238
UR  - https://doi.org/10.3390/biomedicines13092238
ER  - 

APA

Gao, Y., Zhang, Z., Ye, D., Li, Q., Wen, Y., Ma, S., Zheng, B., Chen, L., & Yao, Y. (2025). Association of HTR1F with Prognosis, Tumor Immune Microenvironment, and Drug Sensitivity in Cancer: A Multi-Omics Perspective. Biomedicines. https://doi.org/10.3390/biomedicines13092238

Source records